Master Data

Registry
Register court Düsseldorf HRB 97564
Registered
5/25/2022
Industry
Research and experimental development on biotechnologyDecontamination of nuclear plants and sitesManufacture of basic pharmaceutical products
Purpose
Die Durchführung und Kommerzialisierung von Methoden für die Sicherheits- und Wirksamkeitsbewertung von Substanzen.

History

No events found for this filter

Management

NameRole
Silke Barbara Beaucamp
since 5/25/2022
Managing Director
Managing Director

Beneficial Owners
Beta

Identified persons (12)

NameOwnership
20.73%
K******* E** B*******
11.06%
K******** K***
11.06%

Unresolved chains (4)

Shareholders
Beta

11 shareholders

GmbH structure

5 of 11 shown

Name
Location
Amount
Share
Ellen Fritsche
Düsseldorf
€8,330
25.91%
K******* E** B*******
€4,445
13.83%
K******** K***
€4,445
13.83%
S**** B****** B*******
€4,445
13.83%
High-Tech Gründerfonds III GmbH & Co. KG
Germany
€3,000
9.33%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.